Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 90/100

Failure Rate

33.3%

1 terminated/withdrawn out of 3 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT06502470Not ApplicableCompleted

Healing Study of Fractional Skin Resurfacing and Tissue Histopathology After Ellacor Treatment

Role: collaborator

NCT06421207Not ApplicableCompleted

Open Label Study Exploring Tissue Histopathology After Ellacor® Procedure in an Abdominoplasty Model.

Role: collaborator

NCT04219293Not ApplicableTerminated

Split Face Study of the Effects of Micro Needling With and Without Platelet Rich Plasma

Role: lead

All 3 trials loaded